TheraJect's Grant

TheraJect raised a round of funding on August 02, 2012. Investors include National Science Foundation.

TheraJect is a preclinical stage biopharmaceutical company committed to the drug delivery including vaccines via a needle-free transdermal technology. TheraJect is focused on enhancing the efficacy of…

Articles about TheraJect's Grant: